[HTML][HTML] Combined oral contraceptives in women with systemic lupus erythematosus

…, M Cronin, B Diamond, M Mackay… - … England Journal of …, 2005 - Mass Medical Soc
Background Oral contraceptives are rarely prescribed for women with systemic lupus
erythematosus, because of concern about potential negative side effects. In this double-blind, …

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) …

…, GK Sturfelt, O Nived, C Aranow, M Mackay… - Annals of the …, 2015 - ard.bmj.com
Background and aims We studied damage accrual and factors determining development
and progression of damage in an international cohort of systemic lupus erythematosus (SLE) …

Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95

AM Jacobi, K Reiter, M Mackay… - … : Official Journal of …, 2008 - Wiley Online Library
Objective Analysis of peripheral B cell subsets in patients with systemic lupus erythematosus
(SLE) has provided evidence of specific alterations, such as an expansion of CD27++ …

Selective dysregulation of the FcγIIB receptor on memory B cells in SLE

M Mackay, A Stanevsky, T Wang, C Aranow… - The Journal of …, 2006 - rupress.org
The inappropriate expansion and activation of autoreactive memory B cells and plasmablasts
contributes to loss of self-tolerance in systemic lupus erythematosus (SLE). Defects in the …

Predictors of long‐term renal outcome in lupus nephritis trials: lessons learned from the Euro‐Lupus Nephritis cohort

…, R Cervera, BH Rovin, M Mackay - Arthritis & …, 2015 - Wiley Online Library
Objective There is a need to determine which response measures in lupus nephritis trials
are most predictive of good long‐term renal function. We used data from the Euro‐Lupus …

[HTML][HTML] Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

…, V Giudice, S Lu, SR Brooks, M MacKay… - Nature …, 2021 - nature.com
Increased risk of premature cardiovascular disease (CVD) is well recognized in systemic lupus
erythematosus (SLE). Aberrant type I-Interferon (IFN)-neutrophil interactions contribute to …

Effect of long‐term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double‐blind, placebo‐controlled, dose‐ranging study

…, W Freimuth, I Sanz, R Furie, M Mackay… - … : Official Journal of …, 2010 - Wiley Online Library
Objective To understand the effects of long‐term BLyS inhibition in human systemic lupus
erythematosus (SLE). Methods Seventeen patients with SLE who were enrolled in a clinical …

[HTML][HTML] Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays

QL Zhen, C Xie, T Wu, M Mackay… - The Journal of …, 2005 - Am Soc Clin Investig
Nephrophilic autoantibodies dominate the seroprofile in lupus, but their fine specificities
remain ill defined. We constructed a multiplexed proteome microarray bearing about 30 …

[HTML][HTML] The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus

I Ben-Zvi, C Aranow, M Mackay, A Stanevsky… - PloS one, 2010 - journals.plos.org
Background Excessive activity of dendritic cells (DCs) is postulated as a central disease
mechanism in Systemic Lupus Erythematosus (SLE). Vitamin D is known to reduce …

[HTML][HTML] Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study

…, CE Collins, I Blanco, L Su, B Hojaili, M Mackay… - Arthritis research & …, 2009 - Springer
Introduction TNF-like weak inducer of apoptosis (TWEAK) has been implicated as a mediator
of chronic inflammatory processes via prolonged activation of the NF-κB pathway in several …